Chungen Lan

689 total citations
10 papers, 505 citations indexed

About

Chungen Lan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chungen Lan has authored 10 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Chungen Lan's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Chungen Lan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Chungen Lan collaborates with scholars based in China, United States and United Kingdom. Chungen Lan's co-authors include Xiuchao Wang, Jihui Hao, Shengyu Yang, Chongbiao Huang, He Ren, Tiansuo Zhao, Mingxiao Lang, Jie Dong, Chao Zheng and Xiaoqing Li and has published in prestigious journals such as Cancer Research, Oncogene and Cancer Letters.

In The Last Decade

Chungen Lan

10 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chungen Lan China 8 230 210 167 142 69 10 505
Jingtian Mu China 4 273 1.2× 248 1.2× 142 0.9× 168 1.2× 84 1.2× 8 543
Zengxun Li China 11 255 1.1× 298 1.4× 156 0.9× 207 1.5× 61 0.9× 14 603
Bowie Y. Cheng Hong Kong 6 229 1.0× 306 1.5× 199 1.2× 187 1.3× 58 0.8× 9 600
Joseph Clara United States 6 317 1.4× 356 1.7× 153 0.9× 186 1.3× 76 1.1× 12 638
Dorcas A. Annan Japan 10 235 1.0× 320 1.5× 180 1.1× 193 1.4× 66 1.0× 14 574
Enzo Gallo Italy 15 179 0.8× 290 1.4× 109 0.7× 154 1.1× 51 0.7× 33 547
Mary Hahn United States 5 202 0.9× 294 1.4× 107 0.6× 197 1.4× 40 0.6× 7 531
Adeleye O. Adeshakin China 9 219 1.0× 267 1.3× 254 1.5× 164 1.2× 83 1.2× 19 552
Tingyan Ruan China 8 232 1.0× 280 1.3× 249 1.5× 135 1.0× 34 0.5× 10 542
Veronica Veschi Italy 16 266 1.2× 444 2.1× 114 0.7× 181 1.3× 49 0.7× 26 701

Countries citing papers authored by Chungen Lan

Since Specialization
Citations

This map shows the geographic impact of Chungen Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chungen Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chungen Lan more than expected).

Fields of papers citing papers by Chungen Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chungen Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chungen Lan. The network helps show where Chungen Lan may publish in the future.

Co-authorship network of co-authors of Chungen Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Chungen Lan. A scholar is included among the top collaborators of Chungen Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chungen Lan. Chungen Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wang, Xiuchao, Yunzhan Li, Zekun Li, et al.. (2022). Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Research. 82(12). 2254–2268. 76 indexed citations
2.
Lan, Chungen, Huikun Zhang, Kezhen Wang, et al.. (2022). The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression. Cell Death and Disease. 13(9). 835–835. 7 indexed citations
3.
Lan, Chungen, Bo Ni, Tiansuo Zhao, et al.. (2022). An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers. Frontiers in Genetics. 13. 866702–866702. 3 indexed citations
4.
Dong, Jie, Jie Yu, Zekun Li, et al.. (2021). Serum insulin‐like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma‐associated malnutrition and muscle wasting. Journal of Cachexia Sarcopenia and Muscle. 12(3). 704–716. 22 indexed citations
5.
Wang, Xiuchao, Xin Li, Xunbin Wei, et al.. (2020). PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduction and Targeted Therapy. 5(1). 38–38. 97 indexed citations
6.
Wang, Xiuchao, Jie Dong, Li Jia, et al.. (2017). HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinoma. Cancer Letters. 393. 113–124. 35 indexed citations
7.
Zhao, Xiao, Xiuchao Wang, Lijun Fang, et al.. (2017). A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer. Cancer Letters. 402. 61–70. 59 indexed citations
8.
Lan, Chungen, et al.. (2017). Integrated analysis of gene expression and copy number variations in MET proto‑oncogene‑transformed human primary osteoblasts. Molecular Medicine Reports. 17(2). 2543–2548. 2 indexed citations
9.
Wang, Xiuchao, Mingxiao Lang, Tiansuo Zhao, et al.. (2016). Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. Oncogene. 36(21). 3048–3058. 173 indexed citations
10.
Lang, Mingxiao, Xiuchao Wang, Hongwei Wang, et al.. (2016). Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma. Cancer Letters. 378(2). 87–96. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026